Medreich PLC is a fully integrated pharmaceutical company specializing in the provision of services to CMOs (Contract Manufacturing Organizations) and CDMOs (Contract Development & Manufacturing Organizations). Established in 1995, Medreich operates from its headquarters at Warwick House, Feltham, TW13 7HF, with a global reach. The company’s core business model centers around acting as a strategic partner for pharmaceutical companies seeking to outsource various stages of drug development and manufacturing. Medreich’s primary focus is on offering comprehensive solutions encompassing formulation development, analytical testing, regulatory support, and manufacturing services. They cater to a diverse range of pharmaceutical clients, including both established global players and emerging companies. The company’s international presence is significant, with operations spanning multiple continents. Medreich’s SIC codes reflect its industry focus, encompassing wholesale of pharmaceutical goods (SIC: -46460) and the provision of specialized services related to pharmaceutical development and manufacturing. The company is structured as a type of plc, indicating a privately held, publicly traded entity. Medreich is currently active and maintains a rating of Worker (A) with Visa: Global Business Mobility.

Medreich PLC is a fully integrated pharmaceutical company specializing in the provision of services to CMOs (Contract Manufacturing Organizations) and CDMOs (Contract Development & Manufacturing Organizations). Established in 1995, Medreich operates from its headquarters at Warwick House, Feltham, TW13 7HF, with a global reach. The company’s core business model centers around acting as a strategic partner for pharmaceutical companies seeking to outsource various stages of drug development and manufacturing. Medreich’s primary focus is on offering comprehensive solutions encompassing formulation development, analytical testing, regulatory support, and manufacturing services. They cater to a diverse range of pharmaceutical clients, including both established global players and emerging companies. The company’s international presence is significant, with operations spanning multiple continents. Medreich’s SIC codes reflect its industry focus, encompassing wholesale of pharmaceutical goods (SIC: -46460) and the provision of specialized services related to pharmaceutical development and manufacturing. The company is structured as a type of plc, indicating a privately held, publicly traded entity. Medreich is currently active and maintains a rating of Worker (A) with Visa: Global Business Mobility.